fda approved glp 1 Wegovy Pill Wins Approval as First GLP-1 Oral Treatment for Obesity and Weight Loss GLP-1 Drug Savings: A Complete
Description
In large studies, GLP-1 therapies reduced body weight by an average of 4.57 kg, body mass index by 2.07 kg/m, and waist circumference by 4.55 cm compared with placebo
The active ingredient in Trulicity is dulaglutide, which is different than semaglutide
Losing 20 to 30 pounds on GLP-1 medications doesnt replace exercise, nutrition, sleep, and other healthy lifestyle changes
GLP-1 microdosing generally involves doses lower than those outlined in standard prescribing guidelines, which makes it an off-label use
Regarding their use in KTRs with T2DM, data remain sparse
Only a small number of people need to stop treatment because of side effects
